Company profile
Insight Molecular Diagnostics Inc. Insider Trading
IMDXEvery SEC Form 4 insider trading filing for Insight Molecular Diagnostics Inc. (IMDX) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- In Vitro & In Vivo Diagnostic Substances
- CIK
- 0001642380
- Filings
- 60
- Insiders
- 14
- Last filing
- 2026-07-01
Activity summary
No insider transactions in the last 30 days. The most recent was on July 1, 2026, when Andrew Arno sold 12,100 shares. 60 filings from 14 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Insight Molecular Diagnostics Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $13.0M.
90 day insight
Over the last 90 days, Insight Molecular Diagnostics Inc. insiders sold $156K across 3 transactions with no open-market purchases.
- Most active insider: Andrew Arno with 1 transaction totaling $69K.
- Largest single sale: $69K by Andrew Arno on Jul 1, 2026.
Activity skews bearish — sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Andrew Arno | IMDX | Tax Withholding | 12,100 | $5.69 | $69K |
| Jul 1, 2026 | Andrew J. Last | IMDX | Tax Withholding | 7,700 | $5.69 | $44K |
| Jul 1, 2026 | Lou Silverman | IMDX | Tax Withholding | 7,700 | $5.69 | $44K |
| Jun 11, 2026 | Lou Silverman | IMDX | Award | 26,943 | — | — |
| Jun 11, 2026 | Andrew J. Last | IMDX | Award | 26,943 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=IMDX" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Insight Molecular Diagnostics Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →